DOI QR코드

DOI QR Code

The protective efficacy of the enterotoxigenic Escherichia coli vaccine candidate by GI24 against neonatal piglet colibacillosis

  • Choi, Yeong Hwan (College of Veterinary Medicine, Chonbuk National University) ;
  • Moon, Ja Young (College of Veterinary Medicine, Chonbuk National University) ;
  • Seo, Byoung Joo (College of Veterinary Medicine, Chonbuk National University) ;
  • Kim, Won Kyung (College of Veterinary Medicine, Chonbuk National University) ;
  • Cho, Jeong Sang (College of Veterinary Medicine, Chonbuk National University) ;
  • Choi, Min Su (College of Veterinary Medicine, Chonbuk National University) ;
  • Lim, Jae Sam (Chungcheongnam-Do Livestock Technology Research Institute) ;
  • Kim, Sung Bok (Chungcheongnam-Do Livestock Technology Research Institute) ;
  • Kim, Won Il (College of Veterinary Medicine, Chonbuk National University) ;
  • Hur, Jin (College of Veterinary Medicine, Chonbuk National University)
  • Received : 2017.11.12
  • Accepted : 2017.12.06
  • Published : 2017.12.30

Abstract

Enterotoxigenic Escherichia coli (ETEC) strains producing each F4, F5, F6 and F41 fimbriae were lysed by GI24 peptide. The lysate cells were used as ETEC vaccine candidate. This study was carried out to examine whether intramuscular (im) immunization of pregnant sows with the novel vaccine candidate could effectively protect their neonatal piglets against ETEC colibacillosis. All pregnant sows were primed at 11 weeks and were boosted at 14 weeks of pregnancy. Group A sows were im inoculated with PBS. Group B sows were im immunized with $2{\times}10^9$ the mixture. Seral IgG, colostral IgA and IgG titers from group B sows, and seral IgG and IgA levels in group B piglets were significantly higher than those of group A sows and piglets, respectively. After challenge with wild-type ETEC, diarrhea and mortality was not observed in group B piglets. However, diarrhea was observed in 66.7% of group A piglets, and 33.3% mortality was observed. These findings indicate that im immunization of sows with the mixture of the novel vaccine candidate can effectively protect their offspring from ETEC colibacillosis.

Keywords

References

  1. Arora A, Rinehart D, Szabo G, Tamm, LK. 2000. Refolded outer membrane protein A of Escherichia coli forms ion channels with two conductance states in planar lipid bilayers. J Biol Chem 275: 1594-1600. https://doi.org/10.1074/jbc.275.3.1594
  2. Ascon M, Hone DH, Walters N, Pascual DW. 1998. Oral immunization with a Salmonella Typhimurium vaccine vector expressing recombinant enterotoxigenic Escherichia coli K99 fimbriae elicits elevated antibody titers for protective immunity. Infect Immun 66: 5470-5476.
  3. Baek JH, Lee SH. 2010. Isolation and molecular cloning of venom peptides from Orancistrocerus drewseni (Hymenoptera: Eumenidae). Toxicon 55: 711-718. https://doi.org/10.1016/j.toxicon.2009.10.023
  4. Bertschinger HU, Fairbrother JM. 1999. Escherichia coli infections. In: Straw, B.E., D'Allaire, S., Mengeling, W.L., Taylor, D. (Eds.), Diseases of Swine. Iowa State University Press, Ames, IA: 431-468.
  5. Brumme S, Arnold T, Sigmarsson H, Lehmann J, Scholz HC, Hardt WD, Hensel A, Truyen U, Roesler U. 2007. Impact of Salmonella Typhimurium DT104 virulence factors invC and sseD on the onset, clinical course, colonization patterns and immune response of porcine salmonellosis. Vet Microbiol 124: 274-285. https://doi.org/10.1016/j.vetmic.2007.04.032
  6. Carballar-Lejarazu R, Rodriguez MH, de la Cruz Hernandez-Hernandez F, Ramos-Castaneda J, Possani LD, Zurita-Ortega M, Reynaud-Garza E, Hernandez-Rivas R, Loukeris T, Lycett G, Lanz-Mendoza H. 2008. Recombinant scorpine: a multifunctional antimicrobial peptide with activity against different pathogens. Cell Mol Life Sci 65: 3081-3092. https://doi.org/10.1007/s00018-008-8250-8
  7. Causey RC, Artiushin SC, Crowley IF, Weber JA, Homola AD, Kelley A, Stephenson LA, Opitz HM, Guilmain S, Timoney JF. 2010. Immunisation of the equine uterus against Streptococcus equi subspecies zooepidemicus using an intranasal attenuated Salmonella vector. Vet J 184: 156-161. https://doi.org/10.1016/j.tvjl.2009.05.001
  8. Chen H, Schifferli DM. 2000. Mucosal and systemic immune response to chimeric fimbriae expressed by Salmonella enterica serovar Typhimurium vaccine strains. Infect Immun 68: 3129-3139. https://doi.org/10.1128/IAI.68.6.3129-3139.2000
  9. Chen X, Gao S, Jiao X, Liu XF. 2004. Prevalence of serogroups and virulence factors of Escherichia coli strains isolated from pigs with post weaning diarrhoea in eastern China. Vet Microbiol 103: 13-20. https://doi.org/10.1016/j.vetmic.2004.06.014
  10. Deprez P, Van den Hende C, Muylle E, Oyaert W. 1986. The influence of the administration of sow's milk on the post-weaning excretion of hemolytic E. coli in the pig. Vet Res Commun 10: 469-478. https://doi.org/10.1007/BF02214010
  11. Dobrzynska I, Szachowicz-Petelska B, Sulkowski S, Figaszewski Z. 2005. Changes in electric charge and phospholipids composition in human colorectal cancer cells. Mol Cell Biochem 276: 113-119. https://doi.org/10.1007/s11010-005-3557-3
  12. Ewaschuk JB, Murdoch GK, Johnson IR, Madsen KL, Field CJ. 2011. Glutamine supplementation improves intestinal barrier function in a weaned piglet model of Escherichia coli infection. Br J Nutr 106: 870-877. https://doi.org/10.1017/S0007114511001152
  13. Haesebrouck F, Pasmans F, Chiers K, Maes D, Ducatelle R, Decostere A. 2004. Efficacy of vaccines against bacterial diseases in swine: what can we expect? Vet Microbiol 100: 255-268. https://doi.org/10.1016/j.vetmic.2004.03.002
  14. Haines LR, Thomas JM, Jackson AM, Eyford BA, Razavi M, Watson CN, Gowen B, Hancock RE, Pearson TW. 2009. Killing of trypanosomatid parasites by a modified bovine host defense peptide, BMAP-18. PLoS Negl Trop Dis 3: e373. https://doi.org/10.1371/journal.pntd.0000373
  15. Halas D, Hansen CF, Hampson DJ, Mullan BP, Kim JC, Wilson RH, Pluske JR. 2010. Dietary supplementation with benzoic acid improves apparent ileal digestibility of total nitrogen and increases villous height and caecal microbial diversity in weaner pigs. Anim Feed Sci Technol 160: 137-147. https://doi.org/10.1016/j.anifeedsci.2010.07.001
  16. Harmsen MM, van Solt CB, Hoogendoorn A, van Zijderveld FG, Niewold TA, van der Meulen J. 2005. Escherichia coli F4 fimbriae specific llsma single-domain antibody fragments effectively inhibit bacterial adhesion in vitro but poorly protect against diarrhorea. Vet Microbiol 111: 89-98. https://doi.org/10.1016/j.vetmic.2005.09.005
  17. Holmgren J, Czerkinsky C. 2005. Mucosal immunity and vaccines. Nat Med 11: S45-S53. https://doi.org/10.1038/nm1213
  18. Hur J, Lee JH. 2010. Immunization of pregnant sows with a novel virulence gene deleted live Salmonella vaccine and protection of their suckling piglets against salmonellosis. Vet Microbiol 143: 270-276. https://doi.org/10.1016/j.vetmic.2009.11.034
  19. Hur J, Lee JH. 2011. Immune responses to new vaccine candidates constructed by a live attenuated Salmonella Typhimurium delivery system expressing Escherichia coli F4, F5, F6, F41 and intimin adhesin antigens in a murine model. J Vet Med Sci 73: 1265-1273. https://doi.org/10.1292/jvms.11-0087
  20. Hur J, Lee JH. 2012. Development of a novel live vaccine delivering enterotoxigenic Escherichia coli fimbrial antigens to prevent post-weaning diarrhea in piglets. Vet Immunol Immunopathol 146: 283-288. https://doi.org/10.1016/j.vetimm.2012.02.002
  21. Hur J, Lee JH. 2013. Protection against neonatal Escherichia coli diarrhea by vaccination of sows with a novel multivalent vaccine candidate expressing E. coli adhesins associated with neonatal pig coli bacillosis. Res Vet Sci 94: 198-204. https://doi.org/10.1016/j.rvsc.2012.08.004
  22. Husseiny MI, Hensel M. 2009. Evaluation of Salmonella live vaccines with chromosomal expression cassettes for translocated fusion proteins. Vaccine 27: 3780-3787. https://doi.org/10.1016/j.vaccine.2009.03.053
  23. Jalava K, Hensel A, Szostak M, Resch S, Lubitz W. 2002. Bacterial ghosts as vaccine candidates for veterinary applications. J Control Release 85: 17-25. https://doi.org/10.1016/S0168-3659(02)00267-5
  24. Jawale CV, Chaudhari AA, Jeon BW, Nandre RM, Lee HH. 2012. Characterization of a novel inactivated Salmonella enteritica serovar Enteritidis vaccine candidate generated using a modified cI857/${\lambda}P_R$/gene E expression. Infect Immun 80: 1502-1509. https://doi.org/10.1128/IAI.06264-11
  25. Jawale CV, Lee JH. 2014. Salmonella enterica serovar Enteritidis ghost carrying the Escherichia coli heat-labile enterotoxin B subunit are capable of inducing enhanced protective immune responses. Clin Vaccine Immunol 21: 799-807. https://doi.org/10.1128/CVI.00016-14
  26. Kang HY, Srinivasan J, Curtis III R. 2002. Immune response to recombinant pneumococcal PspA antigen delivered by live attenuated Salmonella enterica serovar Typhimurium vaccine. Infect Immun 70: 1739-1749. https://doi.org/10.1128/IAI.70.4.1739-1749.2002
  27. Katrien V, Vesna M, Eric C, Paul RJ, Chris V. 2011. Adjuvant effect of Gantrez$^{(R)}$ AN nanoparticles during oral vaccination of piglets against F4+enterotoxigenic Escherichia coli. Vet Immunol Immunopathol 139: 148-155. https://doi.org/10.1016/j.vetimm.2010.09.009
  28. Kim YJ, Kim JH, Hur J, Lee JH. 2010. Isolation of Escherichia coli from piglets in South Korea with diarrhea and characteristics of the virulence genes. Can J Vet Res 74: 59-64.
  29. Kiros TG, van Kessel J, Babiuk LA, Gerdts V. 2011. Induction, regulation and physiological role of IL-17 secreting helper T-cells isolated from PMMC, thymus, and lung lymphocytes of young pigs. Vet Immunol Immunopathol 144: 448-454. https://doi.org/10.1016/j.vetimm.2011.08.021
  30. Kramer DR, Sutherland RM, Bao S, Husband AJ. 1995. Cytokine mediated effects in mucosal immunity. Immunol Cell Biol 73: 389-396. https://doi.org/10.1038/icb.1995.61
  31. Lambert GP. 2009. Stress-induced gastrointestinal barrier dysfunction and its inflammatory effects. J Anim Sci 87: E101-108. https://doi.org/10.2527/jas.2008-1339
  32. Lessard M, Dupuis M, Gagnon N, Nadeau E, Matte JJ, Goulet J, Fairbrother JM. 2009. Administration of Pediococcus acidilactici or Saccharomyces cerevisiae boulardii modulates development of porcine mucosal immunity and reduces intestinal bacterial translocation after Escherichia coli challenge. J Anim Sci 87: 922-934. https://doi.org/10.2527/jas.2008-0919
  33. Li XQ, Zhu YH, Zhang HF, Yue Y, Cai ZX, Lu QP, Zhang L, Weng XG, Zhang F, Zhou D, Yang JC, Wang JF. 2012. Risks associated with high-dose Lactobacillus rhamnosus in an Escherichia coli model of piglet diarrhoea: Intestinal microbiota and immune imbalances. PLoS ONE 7: e40666. https://doi.org/10.1371/journal.pone.0040666
  34. Liao CW, Lin SH, Lin PY, Chiou HY, Chang WF, Weng CN. 2004. Orally administrable enterotoxigenic Escherichia coli vaccine encapsulated by ethylcellulose powder dispersion. Appl Microbiol Biotechnol 65: 295-300.
  35. Liu S, Li Y, Xu Z. 2013. Induction of specific immune responses in piglets by intramuscular immunization with fimbrial adhesin FaeG expressed in Lactoccus lactis. Res Vet Sci 95: 130-136. https://doi.org/10.1016/j.rvsc.2013.03.004
  36. Lv Y, Wang J, Gao H, Wang Z, Dong N, Ma Q, Shan A. 2014. Antimicrobial properties and membrane-active mechanism of a potential ${\alpha}$-helical antimicrobial derived from cathelicidin PMAP-36. PLoS One 9: e86364. https://doi.org/10.1371/journal.pone.0086364
  37. Marciani D. 2003. Vaccine adjuvants: role and mechanisms of action in vaccine immunogenicity. Drug Discov Today 8: 934-943. https://doi.org/10.1016/S1359-6446(03)02864-2
  38. Matic JN, Terry TD, Bockel DV, Maddocks T, Tinworth D, Jennings MP, Djordjevic SP, Walker M. 2009. Development of non-antibiotic-resistant, chromosomally based, constitutive and inducible expression systems for aroA attenuated Salmonella enterica serovar Typhimurium. Infect Immun 77: 1817-1826. https://doi.org/10.1128/IAI.01301-08
  39. Mayr UB, Haller C, Haidinger W, Atrasheuskaya A, Bukin E, Lubitz W, Ignatyev G. 2005a. Bacterial ghosts as an oral vaccine: a sing dose of Escherichia coli O157:H7 bacterial ghosts protects mice against lethal challenge. Infect Immun 73: 4810-4817. https://doi.org/10.1128/IAI.73.8.4810-4817.2005
  40. Mayr UB, Walcher P, Azimpour C, Riedmann E, Haller C, Lubitz W. 2005b. Bacterial ghosts as antigen delivery vehicles. Adv Drug Deliv Rev 57: 1381-1391. https://doi.org/10.1016/j.addr.2005.01.027
  41. Meeusen ENT, Walker J, Peters A, Pastoret PP, Jungersen G. 2007. Current status of veterinary vaccines. Clin Microbiol Rev 20:489. https://doi.org/10.1128/CMR.00005-07
  42. Moreto M, Perez-Bosque A. 2009. Dietary plasma proteins, the intestinal immune system, and the barrier functions of the intestinal mucosa. J Anim Sci 87: E92-100. https://doi.org/10.2527/jas.2008-1381
  43. Moyle PM, McGeary RP, Blanchfield JT, Toth I. 2004. Mucosal immunisation: adjuvants and delivery systems. Curr Drug Deliv 1: 385-396. https://doi.org/10.2174/1567201043334588
  44. Nagy B, Fekete PZ. 1999. Enterotoxigenic Escherichia coli in farm animals. Vet Res 30: 259-284.
  45. Nagy B, Fekete PZ. 2005. Enterotoxigenic Escherichia coli in veterinary medicine. Int J Med Microbiol 295: 443-454. https://doi.org/10.1016/j.ijmm.2005.07.003
  46. Nataro JP, Kaper JB. 1998. Diarrheagenic Escherichia coli. Clin Microbiol Rev 11: 142-201.
  47. Pace JL, Rossi HA, Esposito VM, Frey SM, Tucker KD, Walker RI. 1998. Inactivated whole-cell bacterial vaccines: current status and novel strategies. Vaccine 16: 1563-1574. https://doi.org/10.1016/S0264-410X(98)00046-2
  48. Pascual DW, Trunkle T, Sura J. 2002. Fimbriated Salmonella enterica serovar Typhimurium abates initial inflammatory responses by macrophages. Infect Immun 70: 4273-4281. https://doi.org/10.1128/IAI.70.8.4273-4281.2002
  49. Pathangey L, Kohler JJ, Isoda R, Brown TA. 2009. Effect of expression level on immune responses to recombinant oral Salmonella enterica serovar Typhimurium vaccines. Vaccine 27: 2707-2711. https://doi.org/10.1016/j.vaccine.2009.02.072
  50. Puiprom O, Chantaroj S, Gangnonngiw W, Okada K, Honda T, Taniguchi T, Sawanpanyalert P. 2010. Identification of colonization factors of enterotoxigenic Escherichia coli with PCR-based technique. Epidemiol Infect 138: 519-524. https://doi.org/10.1017/S0950268809990720
  51. Remer KA, Barttrow M, Roeger B, Moll H, Sonnenborn U, Oelschlaeger TA. 2009. Split immune response after oral vaccination of mice with recombinant Escherichia coli Nissle 1917 expressing fimbrial adhesin K88. Int J Med Microbiol 299: 467-478. https://doi.org/10.1016/j.ijmm.2009.03.003
  52. Rutter JM, Jones GW. 1973. Protection against enteric disease caused by Escherichia coli-a model for vaccination with a virulence determinant? Nature 242: 531-532. https://doi.org/10.1038/242531a0
  53. Singh SP, Williams YU, Miller S, Nikaido H. 2003. The-C-terminal domain of Salmonella enterica serovar Typhimurium OmpA is an immunodominant antigen in mice but appears to be only partially exposed on the bacterial cell surface. Infect Immun 71: 3937-3946. https://doi.org/10.1128/IAI.71.7.3937-3946.2003
  54. Snoeck V, Huyghebaert N, Cox E, Vermeire A, Vancaeneghem S, Remon JP, Goddeeris BM. 2003. Enteric-coated pellets of F4 fimbriae for oral vaccination of suckling piglets against enterotoxigenic Escherichia coli infections. Vet Immunol Immunopathol 96: 219-227. https://doi.org/10.1016/j.vetimm.2003.08.003
  55. Tabrizi CA, Walcher P, Mayr UB, Stiedl T, Binder M, McGrath J, Lubitz W. 2004. Bacterial ghosts - biological particles as delivery systems for antigens, nucleic acids and drugs. Curr Opin Biotechnol 15 530-537. https://doi.org/10.1016/j.copbio.2004.10.004
  56. Teixeira V, Feio MJ, Bastos M. 2012. Role of lipids in the interaction of antimicrobial peptides with membranes. Prog Lipid Res 51: 149-177. https://doi.org/10.1016/j.plipres.2011.12.005
  57. Vila-Farres X, Garcia de la Maria C, Lopez-Rojas R, Pachon J, Giralt E, Vila J. 2012. In vitro activity of several antimicrobial peptides against colistin-susceptible and colistin-resistant Acinetobacter baumannii. Clin Microbiol Infect 18: 383-387. https://doi.org/10.1111/j.1469-0691.2011.03581.x
  58. Vu-Khac H, Holoda E, Pilipcinec E, Blanco M, Blanco JE, Dahbi G, Mora A, Lopez C, Gonzalez EA, Blanco J. 2007. Serotypes, virulence genes, intimin types and PFGE profiles of Escherichia coli isolated from piglets with diarrhea in Slovakia. Vet J 174: 176-187. https://doi.org/10.1016/j.tvjl.2006.05.019
  59. Yang Y, Zhang Z, Yang J, Chen X, Cui S, Zhu X. 2010. Oral vaccination with Ts87 DNA vaccine delivered by attenuated Salmonella Typhimurium elicits a protective immune response against Trichinella spiralis larval challenge. Vaccine 28: 2735-2742. https://doi.org/10.1016/j.vaccine.2010.01.026